Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 9;9(1):4736.
doi: 10.1038/s41467-018-07254-2.

Inflammation-induced Id2 promotes plasticity in regulatory T cells

Affiliations

Inflammation-induced Id2 promotes plasticity in regulatory T cells

Sung-Min Hwang et al. Nat Commun. .

Abstract

TH17 cells originating from regulatory T (Treg) cells upon loss of the Treg-specific transcription factor Foxp3 accumulate in sites of inflammation and aggravate autoimmune diseases. Whether an active mechanism drives the generation of these pathogenic 'ex-Foxp3 TH17' cells, remains unclear. Here we show that pro-inflammatory cytokines enhance the expression of transcription regulator Id2, which mediates cellular plasticity of Treg into ex-Foxp3 TH17 cells. Expression of Id2 in in vitro differentiated iTreg cells reduces the expression of Foxp3 by sequestration of the transcription activator E2A, leading to the induction of TH17-related cytokines. Treg-specific ectopic expression of Id2 in mice significantly reduces the Treg compartment and causes immune dysregulation. Cellular fate-mapping experiments reveal enhanced Treg plasticity compared to wild-type, resulting in exacerbated experimental autoimmune encephalomyelitis pathogenesis or enhanced anti-tumor immunity. Our findings suggest that controlling Id2 expression may provide a novel approach for effective Treg cell immunotherapies for both autoimmunity and cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial or non-financial interests.

Figures

Fig. 1
Fig. 1
Id2 expression is enhanced during a conversion to TH17 phenotype from iTreg cells. a In vitro polarization scheme of TH0, TH17, iTreg and ex-Foxp3 TH17 cells. b RT-qPCR analysis of Id2 mRNA in in vitro generated TH0, TH17, iTreg and ex-Foxp3 TH17 cells; results are presented relative to Hprt expression (n = 3) c, d Western blot analysis to determine the kinetics of indicated proteins during TH17 (c, top panel) and iTreg (d, top panel) cell differentiation and maintenance conditions. β-actin is used as loading control. RT-qPCR analysis of Il17a, Il17f (c, lower panel) and Il10 (d, lower panel) mRNA during each TH17 and iTreg cell differentiation conditions; results are presented relative to Hprt expression (n = 3). e Sorted CD4+ naive T cells were activated in vitro under iTreg cell differentiation condition for 3 days. After 3 days, iTreg cells were re-stimulated in vitro in ex-Foxp3 TH17 polarizing conditions for additional 3 days. Western blot analyses for the indicated proteins were performed after harvesting the cells at indicated time points (top panel). RT-qPCR analysis of Il10 and Il17a mRNA under similar experimental conditions is shown in the lower panel; results are presented relative to Hprt expression (n = 3). *P < 0.05 (Student’s t-test). Data are representative two independent experiments (error bars, s.d.)
Fig. 2
Fig. 2
Overexpression of Id2 in vitro fails to stabilize iTreg lineage commitment, and convert them into TH17-like cells. a Naive CD4+ T cells were sorted from wild-type C57BL/6 (B6) mice, and transduced with control vector (Empty RV) or vector encoding Id2 cDNA (Id2 RV) under iTreg differentiation condition. After 3 days cells were harvested and Id2 expression was measured by RT-qPCR (n = 3, per group) and Western blot analysis. b Comparison of mRNA expression for T-bet, Gata3, Rorγt and Foxp3 between Empty RV and Id2 RV transduced T cells after 3 days post spinfection under iTreg differentiation condition (n = 3, per group). c Flow cytometry analysis of Foxp3 expression between Empty RV or Id2 RV transduced (GFP+) and non-transduced (GFP) iTreg cells (n = 3, per group). d Comparison of mRNA expression for genes encoding the indicated cytokines between Empty RV and Id2 RV transduced T cells after 3 days post spinfection under iTreg differentiation condition (n = 3, per group). e Flow cytometry analysis of IL-17A, IL-17F and IL-22 from Empty RV or Id2 RV transduced CD4+GFP+ iTreg cells (n = 3, per group). NS, not significant, *P < 0.05, **P < 0.005 (Student’s t-test). All data are representative two or three independent experiments (error bars, s.d.)
Fig. 3
Fig. 3
Mice with Treg-specific ectopic expression of Id2 displayed enhanced conversion to ex-Foxp3 TH17 cells from Treg cells after induction of EAE. a Schematic representation the mouse model employed. Converging arrows in the lower panel indicate genotyping primers. b Genotyping PCR to detect the presence of Id2-EmGFP transgene in Id2EmGFPFoxp3YFP−Cre mice. c Flow cytometry analysis of YFP and EmGFP expression in CD4+CD25+ T cells from spleen (SP) and peripheral lymph nodes (pLN) of Foxp3YFP−Cre and Id2EmGFPFoxp3YFP−Cre mice (left panel). Id2 expression was assessed between non-Treg and Treg cells by intracellular staining (right panel). d Schematic of experimental EAE model. e Representative flow cytometry analysis of Id2 expression between tdTomato+YFP+ (Treg) and tdTomato+YFP(ex-Treg) cells in CD4+ T cells from 6 to 8 week-old R26TFoxp3YFP−Cre mice on day 24 after induction of EAE. f Mean clinical scores in mice after induction of EAE (R26TFoxp3YFP−Cre; n = 12, Id2EmGFPR26TFoxp3YFP−Cre; n = 9). g Representative Spinal Cord (SC) sections and hematoxylin and eosin (H&E) staining from EAE induced mice at day 24 after immunization (scale bar, 100 μm). h Flow cytometry analysis and percentages of Foxp3 sufficient (YFP+) and deficient (YFP) populations among CD4+tdTomato+ in SP and SC from R26TFoxp3YFP−Cre and Id2EmGFPR26TFoxp3YFP−Cre mice at day 22–24 after induction of EAE. i Representative flow cytometry analysis and percentages of IFN-γ+, IL-17A+ and IFN-γ+IL-17A+ in CD4+tdTomato+ YFP or CD4+tdTomato+ YFP+ T cells in total SP and SC cells stimulated with phorbol myristate acetate (PMA) and ionomycin for 6 h. NS,  not significant, *P < 0.05, **P < 0.005, ***P < 0.001 (Student’s t-test). All data are representative of two independent experiments (error bars, s.d.)
Fig. 4
Fig. 4
Treg-cell-specific overexpression of Id2 results in systemic autoimmunity in older mice. a A representative picture of 12–16 week-old Foxp3YFP−Cre and Id2EmGFPFoxp3YFP−Cre mice (left) and spleen (SP) and peripheral lymph nodes (pLN) derived from them (right). b Representative hematoxylin and eosin (H&E)-stained skin, lung, liver sections from 12–16 weeks old Foxp3YFP−Cre and Id2EmGFPFoxp3YFP−Cre mice (scale bar, 100 μm). c Representative FACS plots and percentages of CD4+ and CD8+ T cells from SP and pLN of 12–16 weeks old Foxp3YFP−Cre and Id2EmGFPFoxp3YFP−Cre mice. d, e Representative FACS plots and percentages of CD62LhiCD44lo (naive) and CD62LloCD44hi (effector/memory) cells among CD4+ and CD8+ T cells in SP and pLN 12–16 week-old mice. f Representative FACS plots and percentages of Foxp3+ Treg cells in thymus, SP and pLN from 12–16 week-old mice. NS,  not significant, *P < 0.05, **P < 0.005 (Student’s t-test). All data are representative three independent experiments (error bars, s.d.)
Fig. 5
Fig. 5
Id2 is induced by IL-1β and IL-6 mediated signaling and downstream transcription factors STAT3, IRF4 and BATF in Treg cells. a Strategy for sorting TNaive, iTreg, and ex-Foxp3 TH17 cells from Foxp3Thy1.1 reporter mice (left). Flow cytometry analysis of IL-1r1 and IL-6rα among the TNaive, iTreg, and ex-Foxp3 TH17 cells (right). b, c FACS-sorted iTreg cells were re-stimulated with cytokines as indicated and analyzed for Id2 and Foxp3 mRNA expression by RT-qPCR (b) as well as for Id2 protein levels by flow cytometry (c). d Cartoon depicting highly putative STAT3, IRF4, and BATF binding motifs upstream of Id2 transcription start site (TSS). e Cartoon depicting Id2 promoter constructs used for luciferase reporter assay. f Id2 promoter-luciferase construct (−582/+36) were co-transfected with the combination of STAT3, IRF4 and BATF expressing vectors in HEK-293 T cells. Lysates were prepared 30 h after transfection, and luciferase activities were measured with the reporter activities normalized to renilla luciferase activity. *P < 0.05, **P < 0.005, ***P < 0.001 (Student’s t-test). All data are representative three independent experiments with similar results (error bars, s.d.)
Fig. 6
Fig. 6
Id2 expression inhibits enrichment and transcriptional activity of E2A on Foxp3 promoter. a RT-qPCR analysis of Foxp3, E2A and Id2 mRNA in in vitro generated TH0, TH17, ex-Foxp3 TH17, and iTreg cells. b ChIP-qPCR analysis for E2A occupancy at three putative E-box sites on Foxp3 promoter regions (−1593 to −1584, −1295 to −1286, and −837 to −829) and negative control (−411 to −244; No E-box site) in iTreg and ex-Foxp3 TH17 cells. Enrichments are calculated relative to the input chromatin for corresponding sites. c Jurkat cells were transfected with either Foxp3 promoter reporter construct alone or along with expression plasmids encoding E2A and Id2 as indicated, followed by luciferase assay. d Effect of mutagenesis on Foxp3 promoter reporter activity. Jurkat cells were transiently co-transfected with the indicated plasmids for luciferase assay as described. N = Normal E box, X = Mutated E box. NS,  not significant, *P < 0.05, **P < 0.005, ***P < 0.001 (Student’s t-test). All data are representative of two or three independent experiments (error bars, s.d.)
Fig. 7
Fig. 7
Id2 dependent Treg plasticity enhances antitumor immunity. a Schematic for doxycycline (Dox)-inducible Id2 overexpression in Treg cells in TetR-Id2EmGFPFoxp3YFP−Cre mice. b Id2 expression was assessed by intracellular staining in SP and pLN from both PBS or Dox treated groups. c Experimental scheme of mouse melanoma model. Females, 8–10 week-old, TetR-Id2EmGFPFoxp3YFP−Cre mice were injected subcutaneously with B16.F10 cells. Mice were treated intraperitoneally either with PBS or Dox from day 0–9, every 72 h. d Tumor progression, expressed as mean tumor volume (mm3) in both treatment groups (PBS; n = 8, Dox; n = 8). e Representative tumor size in PBS and Dox treated groups on d 23. f Difference in tumor weight, as measured at end point of analysis (PBS; n = 8, Dox; n = 8). g Flow cytometry analysis of CD4+Foxp3+ T cells in tumor-draining lymph nodes (dLN), non-draining lymph nodes (non-dLN) as well as within tumor infiltrated lymphocytes. h Intracellular staining of cytokines in CD8+ T cells isolated from dLN, non-dLN and tumor infiltrated lymphocytes, stimulated with phorbol myristate acetate (PMA) and ionomycin for 6 h. NS, not significant, *P < 0.05, **P < 0.005, ***P < 0.001 (Student’s t-test). All data are representative of three independent experiments (error bars, s.d.)

Similar articles

Cited by

References

    1. Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 2003;3:253. doi: 10.1038/nri1032. - DOI - PubMed
    1. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012;30:531–564. doi: 10.1146/annurev.immunol.25.022106.141623. - DOI - PMC - PubMed
    1. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity. 2013;38:414–423. doi: 10.1016/j.immuni.2013.03.002. - DOI - PubMed
    1. Hill JA, Benoist C, Mathis D. Treg cells: guardians for life. Nat. Immunol. 2007;8:124. doi: 10.1038/ni0207-124. - DOI - PubMed
    1. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003;4:330. doi: 10.1038/ni904. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources